Roche News | finanzen.ch

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Historisch			Analysen

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Historisch

Analysen

06.12.21	Roche : CHMP Recommends EU Approval Of Actemra/RoActemra To Treat Severe COVID-19 (RTTNews)
06.12.21	Roche To Launch New Test Kits To Detect, Differentiate Between Covid-19 And Influenza Viruses (RTTNews)
18.11.21	Roche Launches New Molecular Diagnostics System Cobas 5800 (RTTNews)
04.11.21	Novartis To Sell 53.3 Mln Roche Shares To Roche For $20.7 Bln (RTTNews)
28.10.21	Roche, Zur Rose Collaborate To Improve Everyday Therapy Management For People Living With Diabetes (RTTNews)
22.10.21	Roche's VENTANA PD-L1 Assay Gets FDA Approval As Companion Diagnostic For Tecentriq In NSCLC (RTTNews)
20.10.21	Roche Q3 Group Sales Rise; Lifts FY21 Outlook - Quick Facts (RTTNews)
18.10.21	Roche Adds Ibex's Image Analysis Tools To Its NAVIFY Digital Pathology Menu - Quick Facts (RTTNews)
18.10.21	Roche announces collaboration with Ibex Medical Analytics to develop artificial intelligence-based digital pathology applications for improved patient care (PR Newswire)
16.10.21	FDA Approves Roche's Tecentriq As Adjuvant Treatment For Early Non-small Cell Lung Cancer (RTTNews)
15.10.21	Roche, PathAI To Develop AI-powered Embedded Image Analysis Workflow For Pathologists (RTTNews)
14.10.21	Genentech: Enspryng Reduces Debilitating Relapses In Neuromyelitis Optica Spectrum Disorder (RTTNews)
14.10.21	Roche To Launch Short Duration Infusion Gazyvaro For Patients In The EU - Quick Facts (RTTNews)
13.10.21	Roche: Long-term Data Reinforces Benefit Of Early Initiation Of OCREVUS In Relapsing MS (RTTNews)
05.10.21	Genentech To Present New Data On Ocrevus In MS And Enspryng In NMOSD (RTTNews)
01.10.21	BioNTech Reports Initiation Of Phase 2 Trial With MRNA Cancer Vaccine Candidate (RTTNews)
30.09.21	Biotech Stocks Facing FDA Decision In October 2021 (RTTNews)
30.09.21	Regeneron's REGEN-COV Data Show Supportive Results In Patients Hospitalized With COVID-19 (RTTNews)
22.09.21	Roche Launches Three Respiratory Test Panels To Detect & Differentiate Common Respiratory Pathogens (RTTNews)
20.09.21	Genentech : Late-stage Trial Data Support Benefit Of Tecentriq In Early-stage Lung Cancer (RTTNews)
17.09.21	Roche Announces Positive CHMP Opinion For Gavreto In RET Fusion-positive Advanced NSCLC (RTTNews)
15.09.21	Roche Launches Digital Pathology Open Environment - Quick Facts (RTTNews)
15.09.21	Regeneron To Supply Additional 1.4 Mln Doses Of COVID-19 Therapy To U.S. (RTTNews)
09.09.21	Roche To Buy TIB Molbiol For Undisclosed Terms - Quick Facts (RTTNews)
07.09.21	Adaptimmune Inks JV With Genentech To Develop Allogeneic T-cell Therapies - Quick Facts (RTTNews)
07.09.21	NeuExcell, Spark Therapeutics To Collaborate To Develop Novel Gene Therapy For Huntington's Disease (RTTNews)
07.09.21	NeuExcell Therapeutics and Spark Therapeutics Announce Research Collaboration Agreement to Develop a Novel Gene Therapy for Huntington's Disease (PR Newswire)
09.08.21	Genentech Says Phase III POLARIX Trial Of Polivy Plus R-CHP Meets Primary Endpoint (RTTNews)
05.08.21	Syros Pharma Reaches Deal With Roche On Colorectal Cancer Treatment (RTTNews)
02.08.21	Carrick Collaborates With Roche To Evaluate Samuraciclib Combination To Treat HR+ Breast Cancer (RTTNews)
29.07.21	FDA Accepts Application For Genentech's Eye Disease Drug Faricimab (RTTNews)
22.07.21	Roche H1 Profit Down; Confirms FY21 Outlook - Quick Facts (RTTNews)
21.07.21	AbbVie: Venetoclax Gets FDA's Breakthrough Therapy Designation In Higher Risk MDS (RTTNews)
20.07.21	Japan Approves Regeneron's Antibody Cocktail To Treat Mild To Moderate COVID-19 (RTTNews)
19.07.21	Roche's Phase III Hemlibra Data Reinforce Safety Profile In People With Haemophilia A (RTTNews)
09.07.21	Roche: WHO Policy Guidelines On Tests To Detect Tuberculosis Now Include Cobas (RTTNews)
30.06.21	Soutenir le retour à la normale du Canada : Roche Diagnostics Canada introduit le nouveau test antigénique rapide nasal SARS-CoV-2, autorisé en vertu de l'arrêté d'urgence de Santé Canada (PR Newswire)
30.06.21	Supporting Canada's back to normal: Roche Diagnostics Canada introduces the new SARS-CoV-2 Rapid Antigen Test Nasal approved under Health Canada's Interim Order (PR Newswire)
28.06.21	Roche: EU Approves ENSPRYNG For Neuromyelitis Optica Spectrum Disorder (RTTNews)
25.06.21	FDA Authorizes Genentech's Actemra To Treat Hospitalized COVID-19 Patients (RTTNews)
24.06.21	Genentech: FDA Accepts BLA For Port Delivery System With Ranibizumab To Treat Wet AMD (RTTNews)
18.06.21	Roche SARS-CoV-2 molecular test granted first FDA Emergency Use Authorization for PCR testing of both symptomatic and asymptomatic individuals at the point of care (PR Newswire)
18.06.21	Roche SARS-CoV-2 molecular test granted first FDA Emergency Use Authorization for PCR testing of both symptomatic and asymptomatic individuals at the point of care (PR Newswire)
17.06.21	Synlogic Partners Roche To Develop Synthetic Biotic Medicine For Inflammatory Bowel Disease (RTTNews)
15.06.21	Roche: Data Across Neuroscience Portfolio Showcase Significant Impact Of Therapies (RTTNews)
11.06.21	AbbVie: 4-year Follow-up Analysis Of Phase 3 Venetoclax Trial Continues To Show Longer PFS In CLL (RTTNews)
11.06.21	Genentech : New Data For Evrysdi Shows Improved Motor Function In Pre-Symptomatic Babies (RTTNews)
09.06.21	Canada Oks Roche's Accu-Chek Inform II Hospital Blood Glucose System For ICU (RTTNews)
09.06.21	Le glycomètre pour hôpitaux Accu-Chek® Inform II de Roche maintenant approuvé par Santé Canada pour une utilisation dans les milieux de soins intensifs (PR Newswire)
09.06.21	Roche's Accu-Chek® Inform II Hospital Blood Glucose System now approved by Health Canada for Intensive Care Use (PR Newswire)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

Swisscom	527.00	2.33 %	K V
Holcim	95.34	1.21 %	K V
UBS Group	30.42	0.86 %	K V
Roche Hldg G	289.00	0.45 %	K V
Swiss Re	141.65	0.35 %	K V
Givaudan	3’850.00	-1.48 %	K V
Lonza Grp	603.80	-1.50 %	K V
Alcon	82.30	-1.53 %	K V
Geberit	508.00	-1.74 %	K V
Part Grp Hldg	1’386.00	-2.26 %	K V

mehr

05.02.25		Roche punktet bei der FDA: Grünes Licht für Susvimo gegen diabetesbedingte Erblindung - Aktie in Grün
25.06.24		Roche kann EU-Zulassung für Multiple-Sklerose-Mittel an Land ziehen - Aktie sinkt dennoch
10.06.24		Roche-Aktie dennoch tiefer: EU-Kommission lässt Lungenkrebsmedikament Alecensa zu
21.05.24		Roche-Aktie schwächer: Roche-Übernahme von LumiraDx in prüfung - Inavolisib erhält "Breakthrough Therapy"-Status
11.12.23		Roche-Aktie etwas fester: Roche legt Studiendaten zu Kadcyla, Hemlibra, Columvi und Lunsumio vor
02.02.23		Roche-Aktie schwächer: Roche erreicht 2022 Prognose - Umsatz- und Gewinnrückgang im neuen Jahr erwartet
27.12.22		Roche-Aktie leichter: FDA lässt Roches Lymphom-Behandlung Lunsumio zu
16.09.22		Roche-Aktie gewinnt: Moody's hebt Bonitätseinstufung für Roche an

05.02.25

Roche punktet bei der FDA: Grünes Licht für Susvimo gegen diabetesbedingte Erblindung - Aktie in Grün

25.06.24

Roche kann EU-Zulassung für Multiple-Sklerose-Mittel an Land ziehen - Aktie sinkt dennoch

10.06.24

Roche-Aktie dennoch tiefer: EU-Kommission lässt Lungenkrebsmedikament Alecensa zu

21.05.24

Roche-Aktie schwächer: Roche-Übernahme von LumiraDx in prüfung - Inavolisib erhält "Breakthrough Therapy"-Status

11.12.23

Roche-Aktie etwas fester: Roche legt Studiendaten zu Kadcyla, Hemlibra, Columvi und Lunsumio vor

02.02.23

Roche-Aktie schwächer: Roche erreicht 2022 Prognose - Umsatz- und Gewinnrückgang im neuen Jahr erwartet